Colorectal cancer is one of the most common tumours among people over the age of 50. Although it is known to develop from ...

UCSF researchers shed light on how cells under stress can change their identity in harmful ways, contributing to pulmonary ...

Long-term continuous OGSIVEO treatment for up to 4 years was associated with further tumor size reductions, increase in objective response rate, sustained improvement in desmoid tumor symptoms and con ...

Although desmoid tumors do not metastasize, they can be associated with recurrence rates of up to 77% after surgical ...

From bars to cereals, the added-ingredient hype is everywhere. Three experts cut through the marketing to reveal the optimal ...

Discusses ESMO Data on TGF-beta Receptor by PD-1 Bispecific in Colorectal Cancer and G12D Inhibitor in Pancreatic ...

Researchers believe a groundbreaking new drug can offer hope to those diagnosed with this deadly breast cancer, creating a ...

Seres Therapeutics, Inc. (Nasdaq: MCRB), (Seres or the Company), a leading live biotherapeutics company, today announced that new post hoc data from its SER-155 Phase 1b trial will be featured in an ...

Enhertu significantly improved IDFS compared to Kadcyla, with a 53% risk reduction in invasive disease or death in high-risk, ...

Whether you’re cutting back on drinking or just looking for a zero-proof alternative, TribeTokes can help you relax and ...